About: A randomized, double-blind, placebo-controlled trial of the oral mesalamine (5-ASA) preparation, Asacol, in the treatment of symptomatic Crohn's colitis and ileocolitis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A randomized, double-blind, placebo-controlled trial of the oral mesalamine (5-ASA) preparation, Asacol, in the treatment of symptomatic Crohn's colitis and ileocolitis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 December 1994

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в грудні 1994 (uk) article scientifique publié en 1994 (fr) im Dezember 1994 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'avientu de 1994 (ast) scientific article published on 01 December 1994 (en)
publication date	wds:Q72592553-B2DB9210-8D33-4277-82C5-573EBE17354E
publication date	1994-12-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q72592553-4FB59615-F3C0-44ED-AF07-5056544C9EEB wds:Q72592553-92AD4B99-0C84-4CA1-833F-0B5B4013F742 wds:Q72592553-F6ED11F9-168E-4CE0-81B3-66F63A243DF3
author name string	W J Tremaine K W Schroeder J M Harrison
rdfs:label	A randomized, double-blind, placebo-controlled trial of the oral mesalamine (5-ASA) preparation, Asacol, in the treatment of symptomatic Crohn's colitis and ileocolitis (en) A randomized, double-blind, placebo-controlled trial of the oral mesalamine (5-ASA) preparation, Asacol, in the treatment of symptomatic Crohn's colitis and ileocolitis (nl)
skos:prefLabel	A randomized, double-blind, placebo-controlled trial of the oral mesalamine (5-ASA) preparation, Asacol, in the treatment of symptomatic Crohn's colitis and ileocolitis (en) A randomized, double-blind, placebo-controlled trial of the oral mesalamine (5-ASA) preparation, Asacol, in the treatment of symptomatic Crohn's colitis and ileocolitis (nl)
name	A randomized, double-blind, placebo-controlled trial of the oral mesalamine (5-ASA) preparation, Asacol, in the treatment of symptomatic Crohn's colitis and ileocolitis (en) A randomized, double-blind, placebo-controlled trial of the oral mesalamine (5-ASA) preparation, Asacol, in the treatment of symptomatic Crohn's colitis and ileocolitis (nl)
author	wds:Q72592553-87BBC9A0-DD46-454A-969C-5A9DFECF020C
author	Alan R. Zinsmeister
title	wds:Q72592553-A2D1676C-5A4D-4FB4-8ABB-BE445F63389F
title	A randomized, double-blind, placebo-controlled trial of the oral mesalamine (5-ASA) preparation, Asacol, in the treatment of symptomatic Crohn's colitis and ileocolitis (en)
page(s)	wds:Q72592553-D56A7D19-D5C9-46C9-B719-4BB7113422FC
page(s)	278-282
instance of	wds:Q72592553-7F29205D-0EF4-4380-84EB-28774DF257D9
instance of	scholarly article
main subject	wds:Q72592553-235B7481-662D-4560-B499-43D6CA5448B0 wds:Q72592553-D5D318E6-B2A2-4387-AB16-E2F84651CFF1 wds:Q72592553-F69CBDBF-DF78-403D-B687-855ABB1194B8
main subject	placebo Crohn's colitis placebo-controlled trial
PubMed ID	wds:Q72592553-01FA89C1-FC2D-45B0-92CA-71E96F262E00
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7876505
PubMed ID	7876505
published in	wds:Q72592553-50964A1B-BAF4-4074-95B0-47087E692217
published in	Journal of Clinical Gastroenterology
issue	wds:Q72592553-633D9ED6-E92B-40AE-99D4-623A049E241D
volume	wds:Q72592553-44CCDD8E-04F3-4960-9BB5-753E14CC7D19
issue	4
volume	19
DOI	wds:Q72592553-E3731642-747D-449E-AE3F-959C51CB929E
DOI	http://dx.doi.org/10.1097/00004836-199412000-00003
DOI	10.1097/00004836-199412000-00003
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q72592553
is cites work of	Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics Therapy of inflammatory bowel disease. Inflammatory bowel disease: clinical aspects and established and evolving therapies Aminosalicylates for induction of remission or response in Crohn's disease Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs Inflammatory bowel disease. Medical therapy of specific clinical presentations Treatment of inflammatory bowel disease: a review of medical therapy Use of thiopurines in inflammatory bowel disease European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Oral delayed-release mesalazine: a review of its use in ulcerative colitis and Crohn's disease Aminosalicylates for induction of remission or response in Crohn's disease Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease Mesalamine in the treatment of mild to moderate active Crohn's ileitis: results of a randomized, multicenter trial Medical therapy for inflammatory bowel disease Update on the management of Crohn's disease Medical therapy of active Crohn's disease. Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: a systematic review. Management of Crohn's disease. Renal effects of long-term treatment with 5-aminosalicylic acid Metastatic Crohn's disease: remission induced by mesalamine and prednisone Role of conventional therapies in the era of biological treatment in Crohn's disease Medical therapy for Crohn's disease: the state of the art. Common misconceptions about 5-aminosalicylates and thiopurines in inflammatory bowel disease. Searching for the delta: 5-aminosalicylic Acid therapy for Crohn's disease Medical treatment of Crohn's disease Management of difficult inflammatory bowel disease: where are we now? Update on the role of modified release mesalamine in the management of ulcerative colitis and Crohn's disease Conventional therapy for Crohn's disease Medical therapy of specific clinical presentations Medical management of Crohn's disease Advances in inflammatory bowel disease Anti-inflammatory effects of 5-aminosalicylic acid conjugates with chenodeoxycholic acid and ursodeoxycholic acid on carrageenan-induced colitis in guinea-pigs 2019 Expert opinion on biological treatment use in inflammatory bowel disease management Medical Therapy of Crohn's Disease Treatment of Crohn’s disease of inflammatory, stenotic, and fistulizing phenotypes [Intestinal Crohn's disease: management] Physicians' Perspectives on Cost, Safety, and Perceived Efficacy Determine Aminosalicylate Use in Crohn's Disease Investigation of a High-Dose pH-Dependent-Release Mesalazine on the Induction of Remission in Active Crohn's Disease Systematic review: outcomes and adverse events from randomised trials in Crohn's disease
is cites work of	wds:Q26824662-33D438DA-999C-40BD-81AD-CC248BD00C01 wds:Q33588549-59E213A4-F15C-451B-8E3E-CD6DA1BB682B wds:Q33819478-8C5750A1-61EC-4463-92E0-F3CAC3B73FE6 wds:Q28390019-76E1EB9F-A687-4B3A-AAF8-BE3CA3BEC4E6 wds:Q33785519-E2A5FC94-C761-4D23-88FC-8AA3A33DE646 wds:Q37058862-EF033BA0-FA17-4833-9491-E25E540787DD wds:Q37892884-AE5A422E-86FE-42D7-A5EB-9D077605829E wds:Q47687470-38A6EA89-B4E9-46C4-91A0-86EC62777239 wds:Q26471183-B92AA03B-7E8B-4C59-9E9A-3FE09486126C wds:Q34745614-6B14DAA5-1C64-4380-A783-1D7EF06CF0D0 wds:Q37223156-A9B869AA-6FBF-48E7-9831-AA8A4EA42FBC wds:Q34057531-05CBEAEB-A040-4580-A951-568AB3B1D95F wds:Q37906356-7C737DB3-E5E7-4EA3-B1FA-CE5219C03240

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software